These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8458609)

  • 1. Potentiating effects of combined usage of three sulfonylurea drugs on the occurrence of alloxan diabetes in rats.
    Katsumata K; Katsumata Y; Ozawa T; Katsumata K
    Horm Metab Res; 1993 Feb; 25(2):125-6. PubMed ID: 8458609
    [No Abstract]   [Full Text] [Related]  

  • 2. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiating effect of glibenclamide on the occurrence of alloxan diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1986 Apr; 18(4):277-8. PubMed ID: 3086202
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical evaluation of gliquidone--short acting sulfonylurea derivative--comparison with glibenclamide and gliclazide].
    Rupprecht E; König E; Limmer J
    Pol Tyg Lek; 1993 Apr; 48 Suppl 1():31-2. PubMed ID: 8516203
    [No Abstract]   [Full Text] [Related]  

  • 6. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
    Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
    Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral management of uncomplicated maturity onset diabetes.
    Mashaly M; el-Ebrashy N; Higazi AM; Einen MA; Aziz MT
    J Egypt Med Assoc; 1974; 57(7-8):288-97. PubMed ID: 4217809
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies].
    Schöffling K; Mehnert H; Ewald W; Haupt E; Wicklmayr M; Beyer J; Nemeth N
    Dtsch Med Wochenschr; 1973 May; 98(18):915-9. PubMed ID: 4633717
    [No Abstract]   [Full Text] [Related]  

  • 9. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
    Tattersall RB
    Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experience with diamicron treatment of diabetics].
    Velikov VK; Shubina IO; Saltykov BB; Frolova AI
    Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of the treatment of diabetes mellitus on the development of cardiac changes in alloxan diabetes].
    Pog'atsa G; Bihari-Varga M; Szinay G
    Orv Hetil; 1980 Jan; 121(2):91-4. PubMed ID: 6768045
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment with glibenclamide in maturity-onset diabetes mellitus.
    Persson I; Madsen SN
    Geriatrics; 1971 May; 26(5):182-95. PubMed ID: 5004113
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of the hypoglycemic activity of glyoxamide and tolbutamide in normal states and in experimental diabetes].
    Khaleeva LD; Timasheva IN; Voronina LN; Petiunin PA; Chernykh VP
    Probl Endokrinol (Mosk); 1981; 27(4):46-8. PubMed ID: 7291151
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of the sulfonylurea glyburide on glutathione-S-transferase and glucose-6-phosphate dehydrogenase in streptozotocin-induced diabetic rat liver.
    Bugdayci G; Altan N; Sancak B; Bukan N; Kosova F
    Acta Diabetol; 2006 Dec; 43(4):131-4. PubMed ID: 17211564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits.
    Watanabe M; Watanabe K; Matsui H
    Vet Hum Toxicol; 2002 Jun; 44(3):140-4. PubMed ID: 12046964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical evaluation of an oral antidiabetic drug.
    Müller R
    Aust N Z J Med; 1971 Aug; 1():Suppl 2:39-46. PubMed ID: 5005130
    [No Abstract]   [Full Text] [Related]  

  • 17. [New aspects of therapy with oral antidiabetic agents].
    Haslbeck M
    Wien Med Wochenschr; 1979 Dec; 199(24):689-95. PubMed ID: 161940
    [No Abstract]   [Full Text] [Related]  

  • 18. Insulin potentiating effect on development of alloxan diabetes and its prevention by the Ca-channel blocker nicardipine.
    Katsumata K; Miyao M; Katsumata Y
    Horm Metab Res; 1998 Sep; 30(9):557-8. PubMed ID: 9808323
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical efficacy of glimepiride].
    Kaneko T; Sakamoto N
    Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative evaluation of the hypoglycemic effect of the 2d-generation sulfonylurea preparations maninil and diamicron in diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Levitskaia ZI; Gincherman LE
    Probl Endokrinol (Mosk); 1982; 28(5):9-11. PubMed ID: 6815639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.